Skip to main content
Clinical Trials/JPRN-UMIN000042120
JPRN-UMIN000042120Completed未知

A database study to understand the current treatment patterns and efficacy of high-dose methotrexate-based therapy in Japanese patients with Primary central nervous system lymphoma - A database study to understand the current treatment patterns and efficacy of high-dose methotrexate-based therapy in Japanese patients with PCNS

Ono Pharmaceutical Co., Ltd.0 sitesStarted: October 14, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Others,meta-analysis etc

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • - Patients whose data period before the index is less than 6 months (183 days) - Patients with a follow-up period of less than 12 months (365 days) - Patients with a cancer recurrence flag on the initial hospitalization record etc.

Investigators

Sponsor
Ono Pharmaceutical Co., Ltd.

Similar Trials